The introduction of a new 1318 nm wavelength Nd:YAG laser has created new possibilities in lung parenchyma surgery. The potentially curative surgical resection of pulmonary metastases in suitably selected cases had been recognized slowly. Using the new laser technology a greater number of patients can now offered salvage surgery. This paper reviews the history of surgical management of pulmonar...

PURPOSE Surgical resection of isolated hepatic or pulmonary metastases of colorectal cancer is an established procedure, with a 5-year survival rate of about 50%. However, the role of surgical resections in patients with both hepatic and pulmonary metastases is not well established. We aimed to analyze overall survival of these patients and associated factors. METHODS Data retrospectively col...

BACKGROUND Few reports discuss the outcome of pulmonary metastasis after radical esophagectomy for esophageal cancer. To clarify the data from such cases, we conducted a retrospective study on the clinical outcome of patients who developed pulmonary metastasis after undergoing radical esophagectomy. METHODS We retrospectively reviewed the prognosis and clinical outcome of 25 patients who deve...

BACKGROUND 40-50% of patients with colorectal cancer (CRC) will develop liver metastases (CRLM) during the course of the disease. One third of these patients will additionally develop pulmonary metastases. METHODS 137 consecutive patients with CRLM, were analyzed regarding survival data, clinical, histological data and treatment. Results were stratified according to the occurrence of pulmonar...

INTRODUCTION The malignant disease's ability to metastasize remains one of the major obstacles when treating patients with cancer. The indication of metastasectomy is currently limited to patients undergoing treatment of the primary tumor. Resections for lung metastases of high selected patients with urogenital cancer present minimal risks and can prolong survival. Prognostic factors that deter...

Pulmonary metastasectomy is nowadays a common practice in thoracic surgery. Clinical prognostic markers for poor outcome after pulmonary metastasectomy have been proposed in the late 1970's of the last century. Despite new insights in molecular mechanisms and advances in imaging techniques, neither molecular markers nor radiological features of metastases are used as prognosticators in routine ...

BACKGROUND The lung is one of the most common sites for extrahepatic metastasis from hepatocellular carcinoma (HCC). This study aimed to assess the efficacy of surgical resection for pulmonary metastases from HCC. MATERIAL AND METHODS The medical records of 9 patients who underwent pulmonary metastasectomy from HCC at 2 institutions were retrospectively studied, together with a review of stud...

Cerenkov luminescence imaging (CLI) has been recently proposed as a method to visualize surgical margins in the operating theater, immediately after resection, allow refining surgery single procedure. Our group is preparing pilot clinical study evaluate impact of CLI during hepatic metastasectomy, using 18 F-FDG and 68 Ga-DOTATOC. Currently, we are optimizing protocol terms patient inclusion cr...